Community/Retail

According to the CDC, approximately 1 of 3 patients with type 1 and 2 diabetes mellitus (DM) has CKD. What do we need to know about patients with DM and CKD?

Bruce Kneeland, community pharmacy consultant, discusses patient education surrounding vaccinations, in an interview with Pharmacy Times.

Dennis Killian, PharmD, PhD, Director of Pharmacy Services, Peninsula Regional Medical Center, Salisbury, MD, discusses how his hospital utilized IV robotics to prepare pharmacy products on site.

Patricia Kienle, BSPHARM, MPA, FASHP director of Accreditation and Medication Safety for Cardinal Health in Dublin, OH discusses the application of sterile compounding standards in hospital areas outside the pharmacy.

In addition to offering on-site free and fast HIV testing, counselors from local agencies will answer questions about HIV prevention and treatment options, including PrEP, at certain Walgreens stores across the country.

Actress Jessica Biel’s public comments place her on an ever-growing list of famous people whose opinions are contributing to a resurgence of preventable diseases.

Bruce Kneeland, community pharmacy consultant, discusses nutritional supplements as an economic opportunity for independent pharmacists, as well as their health benefits to patients.

Pembrolizumab is already an established treatment option for non-small cell lung cancer, with several approved indications for its use in the disease.

Baloxavir marboxil (Xofluza, Genentech) is a first in class antiviral flu treatment and is indicated in the United States for patients age 12 years and older who have been symptomatic for no more than 48 hours.

Liraglutide is the first noninsulin drug approved to treat T2D in pediatric patients since metformin was approved for pediatric use in 2000, according to the FDA.

Dennis Killian, PharmD, PhD, Director of Pharmacy Service at Peninsula Regional Medical Center, Salisbury, MD, discusses motivating factors for the hospital's use of IV automation.

Dr. Michael Kosal takes a data-driven and analytical approach to managing pharmacy operations. In this interview with Lynn Paterini, PharmD, host of The Nontraditional Pharmacist, see what is involved in pharmacy administration, where workdays are never the same.

Why does this patient have a fever, but no signs of an infection?

In this video, sponsored by Cardinal Health, female pharmacists and pharmacy owners discuss what makes a good leader and how they would leave a legacy of leadership in their communities.

The American Society of Health-System Pharmacists (ASHP) awarded Bruce E. Scott, a former president of ASHP, with the 2019 Harvey A.K. Whitney Lecture Award at their summer meetings in Boston.

Tom Kraus of ASHP discusses what they'll be watching for at upcoming FDA listening sessions regarding compounding legislation

Dogs were previously the leading cause of rabies deaths in the United States, but now bats are considered the major threat.

As the pharmacy services industry continues to shift toward more all-around care, an increasing number of pharmacists are implementing physical exams in their practice.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Officials with the FDA approved Amgen’s trastuzumab-anns, also known as ABP 980 (Kanjinti), the fifth FDA-approved biosimilar referencing trastuzumab (Herceptin).

Pharmacists are part of collaborative care models for opioid use disorder (OUD) treatment and suicide prevention.

Patricia Kienle, BSPHARM, MPA, FASHP discusses the different rooms that are used for compounding and how to comply with USP 797 regardless of location in sterile compounding during the American Society of Health-System Pharmacists Summer Meeting in Boston, MA from June 8-12.

Tom Kraus, VP of Government Relations for ASHP, discusses what they're focusing on regarding drug pricing legislation.

A new study finds duel benefit of the varicella vaccine

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new subgroup analysis from the phase 3 CREDENCE study,

The trial analyzed the impact of vitamin K intake on patients who were taking warfarin to decrease the risk of blood clots.

The literature review indicated that there was a significant need for human trafficking (HT) training within emergency departments (ED) and pharmacy school curriculum.

In the statement, USPSTF officials noted that people who take PrEP should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections.

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, Associate Professor, Midwestern University College of Pharmacy – Glendale, Glendale, AZ, discusses management of anticoagulation medications in special populations, including pregnant women and elderly individuals.